M. Prouteau - Concepedia

Author

M. Prouteau

Institut de Biologie systémique et synthétique

Also Known As

M PROUTEAU, M Prouteau, M. PROUTEAU, M. Prouteau, MONIQUE PROUTEAU, Monique Prouteau

Publications

177

Citations

H-Index

Concepts

All Affiliations

Institut de Biologie systémique et synthétique

About

M. Prouteau is an author at Institut de Biologie systémique et synthétique specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	169
2	Allergy	3	3	64
3	Natural Sciences	2	2	37
4	Allergy Medicine	2	2	31
5	Health Sciences	1	1	18

M. Prouteau

Publications

169

Citations

H-Index

Page 1

	Year	Citations
Litoxetine: a selective 5-HT uptake inhibitor with concomitant 5-HT3 receptor antagonist and antiemetic properties I. Angel, H. Schoemaker, M. Prouteau, European Journal of Pharmacology MedicineMechanism Of ActionAntiemetic PropertiesPharmacological AgentPharmacotherapy	1993	38
In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent. Jesús Bénavidès, H. Schoemaker, Corinne Dana, PubMed Molecular PharmacologyAllergyBiochemistryPharmacological StudyMedicine	1995	33
Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent. Julie Levrier, D Duval, M. Prouteau, PubMed AsthmaAllergyAllergy MedicineMedicinePhysiology	1995	21
Synthesis and analgesic activities of some (4-substituted phenyl-1-piperazinyl)alkyl 2-aminobenzoates and 2-aminonicotinates P. Manoury, Andre P. Dumas, H Najer, Journal of Medicinal Chemistry Medicinal ChemistryPharmaceutical ChemistryHeterocyclicPharmacological StudyDerivative (Chemistry)	1979	21
Normalization of insulin secretion by a selective alpha 2-adrenoceptor antagonist restores GLUT-4 glucose transporter expression in adipose tissue of type II diabetic rats. I. Angel, Rémy Burcelin, M. Prouteau, Endocrinology Glucose ToleranceType IiInsulin SignalingMolecular PharmacologyMetabolic Syndrome	1996	18
Sulphasalazine and PhCL28A inhibit the formation of ethanol‐ and phenylbutazone‐induced rat gastric ulcers: lack of involvement of endogenous prostaglandins? Catherine Berry, M. Prouteau, Kenneth G. Lloyd British Journal of Pharmacology Gastrointestinal PharmacologyPbt TreatmentGastroenterologyPathologyPharmacotherapy	1988	16
SL 85.0324: a novel benzimidazole derivative with selective histamine H1-receptor antagonist properties S. Arbilla, H. Schoemaker, B. Scatton, European Journal of Pharmacology Molecular PharmacologyDrug TargetBiochemistryMedicineNovel Benzimidazole Derivative	1990	12
Anti-anaphylactic activity of the non sedative histamime H1 receptor antagonist SL 85.0324 in the rat and guinea pig K.G. Lloyd, Julie Levrier, D Duval, European Journal of Pharmacology AsthmaAllergyAllergy MedicineMedicinePhysiology	1990	10

Page 1